Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world

Clinical trial NCT07356960 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07356960
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Acute Lymphobkastic Leukemia Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Start date: 2026-04-02
Primary completion: 2029-04-30
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.